| Title |
Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
|
|---|---|
| Published in |
Breast Cancer Research and Treatment, February 2015
|
| DOI | 10.1007/s10549-015-3293-7 |
| Pubmed ID | |
| Authors |
Michelle W. Wong-Brown, Cliff J. Meldrum, Jane E. Carpenter, Christine L. Clarke, Steven A. Narod, Anna Jakubowska, Helena Rudnicka, Jan Lubinski, Rodney J. Scott |
X Demographics
The data shown below were collected from the profiles of 30 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 8 | 27% |
| India | 3 | 10% |
| United Kingdom | 2 | 7% |
| Netherlands | 1 | 3% |
| Spain | 1 | 3% |
| Kenya | 1 | 3% |
| Belgium | 1 | 3% |
| Canada | 1 | 3% |
| Slovenia | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 11 | 37% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 23 | 77% |
| Scientists | 7 | 23% |
Mendeley readers
The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Russia | 1 | <1% |
| Unknown | 111 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 18 | 16% |
| Researcher | 16 | 14% |
| Student > Bachelor | 15 | 13% |
| Student > Master | 12 | 11% |
| Student > Doctoral Student | 5 | 4% |
| Other | 20 | 18% |
| Unknown | 27 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 28 | 25% |
| Biochemistry, Genetics and Molecular Biology | 26 | 23% |
| Agricultural and Biological Sciences | 19 | 17% |
| Nursing and Health Professions | 3 | 3% |
| Neuroscience | 3 | 3% |
| Other | 7 | 6% |
| Unknown | 27 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 May 2019.
All research outputs
#1,309,658
of 26,017,215 outputs
Outputs from Breast Cancer Research and Treatment
#143
of 5,117 outputs
Outputs of similar age
#19,152
of 391,111 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#3
of 73 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,117 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 391,111 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 73 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.